Welcome to our dedicated page for Travelers Compan SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for The Travelers Companies, Inc. (NYSE: TRV), a property casualty insurer that offers auto, home and business coverage. Travelers’ filings give investors and analysts detailed information about its financial condition, capital structure, risk profile and governance.
Travelers uses current reports on Form 8-K to disclose material events and updates. For example, a Form 8-K filed on October 16, 2025, furnishes a press release and financial supplement reporting the company’s results for the quarter ended September 30, 2025. Another Form 8-K filed on July 24, 2025, describes an underwriting agreement for the issuance and sale of senior notes due 2035 and 2055, and confirms that Travelers’ common stock trades on the New York Stock Exchange under the symbol TRV.
In addition to 8-Ks, Travelers files annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain segment information for Business Insurance, Bond & Specialty Insurance and Personal Insurance, as well as discussions of underwriting results, catastrophe losses, reserve development, net investment income and capital management. Proxy statements on Schedule 14A and beneficial ownership or insider transaction reports on forms such as Form 4 provide further insight into governance and executive and director share activity.
On Stock Titan, Travelers’ SEC filings are updated from the EDGAR system and presented with AI-powered summaries that highlight key points from lengthy documents. These summaries are designed to help users quickly understand the main drivers of performance, capital actions such as debt issuance, and other material disclosures without reading every page of the underlying filing.
The Travelers Companies, Inc. reported an insider equity award for executive Mojgan M. Lefebvre, EVP & Chief Tech & Ops Officer. The Form 4 shows a grant of 10,651 stock options (Right to Buy) on February 3, 2026.
These options allow the purchase of Travelers common stock at an exercise price of $288.23 per share. They become exercisable on February 3, 2029 and expire on February 3, 2036. Following this transaction, Lefebvre is reported as directly owning 10,651 derivative securities in the form of these options.
Travelers Companies executive Maria Olivo, EVP, ERM & Chief Risk Officer, received a grant of stock options on February 3, 2026. The award covers 10,773 stock options with a conversion or exercise price of $288.23 per share.
These options give the right to buy Travelers common stock and become exercisable on February 3, 2029, with an expiration date of February 3, 2036. Following this transaction, Olivo directly holds 10,773 derivative securities of this type.
The Travelers Companies, Inc. executive Jeffrey P. Klenk, EVP & President, Bond & Specialty Insurance, reported an award of stock options. On February 3, 2026, he acquired 12,854 stock options with a $288.23 exercise price, each for one share of common stock.
These options become exercisable on February 3, 2029 and expire on February 3, 2036. Following this grant, Klenk beneficially owns 12,854 derivative securities directly, as reflected in the filing.
The Travelers Companies, Inc. executive Rowland David Donnay, EVP & Co-Chief Investment Officer, reported a new stock option grant. On February 3, 2026, he was awarded 7,407 stock options with a conversion or exercise price of $288.23 per share.
These options relate to Travelers common stock, are held directly, and expire on February 3, 2036. Following this grant, Donnay beneficially owns 7,407 derivative securities in the form of these stock options.
The Travelers Companies, Inc. executive Michael Frederick Klein, EVP & President, Personal Insurance, reported acquiring stock options on the company’s common stock. On February 3, 2026, he acquired 16,649 stock options (right to buy) with a conversion or exercise price of $288.23 per share.
These options become exercisable on February 3, 2029 and expire on February 3, 2036. After this transaction, Klein beneficially owned 16,649 derivative securities, held directly in his name, with the derivative securities themselves reported at a price of $0.
The Travelers Companies, Inc. reported an insider equity award for its EVP & Chief Financial Officer, Daniel S. Frey. On February 3, 2026, he was granted stock options to buy 13,026 shares of Travelers common stock.
The options have an exercise price of $288.23 per share, become exercisable on February 3, 2029, and expire on February 3, 2036. Following this grant, Frey directly holds 13,026 stock options, with no indirect ownership reported in this filing.
The Travelers Companies, Inc. executive Yin Daniel Tei-Hwa, EVP & Co-Chief Investment Officer, reported a stock option award. On 02/03/2026, he received 7,407 stock options with an exercise price of $288.23 per share, expiring between 02/03/2029 and 02/03/2036.
Following this grant, he beneficially owns 7,407 derivative securities directly.
Travelers Companies executive Gregory C. Toczydlowski received a new stock option grant. On February 3, 2026, he was awarded 17,629 stock options to buy Travelers common stock at an exercise price of $288.23 per share. These options become exercisable on February 3, 2029 and expire on February 3, 2036. Following this award, he beneficially owns 17,629 derivative securities directly.
Travelers Companies’ Chairman and CEO Alan D. Schnitzer reported multiple equity transactions in early February 2026. On February 4, 2026, he exercised 216,246 stock options at $126.18 per share, receiving the same number of common shares.
That day, Schnitzer had 160,513 shares withheld to cover obligations at $294.36 per share and sold additional common stock in three blocks: 26,509 shares at $294.1802, 23,078 shares at $295.0001, and 6,146 shares at $295.8154, based on weighted-average pricing ranges. After these trades, he directly owned 260,329.401 shares of Travelers common stock.
Separately, on February 3, 2026, Schnitzer was granted 88,389 stock options with an exercise price of $288.23, exercisable beginning February 3, 2029 and expiring February 3, 2036. The filing also notes 11,091 shares held indirectly by his spouse, for which he disclaims beneficial ownership.
The Travelers Companies, Inc. reported that EVP and Chief Admin Officer Andy F. Bessette received a grant of stock options. On February 3, 2026, he was awarded options to buy 6,427 shares of Travelers common stock at an exercise price of $288.23 per share.
These options relate to 6,427 underlying common shares, become exercisable on February 3, 2029, and expire on February 3, 2036. Following this grant, Bessette directly beneficially owns 6,427 derivative securities in the form of these stock options.